AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
AGE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -2.46%144.460.7%$923.06m
PFEPfizer Inc. -0.37%37.810.9%$790.83m
BMYBristol-Myers Squibb Co. -0.75%60.781.0%$657.39m
MRKMerck & Co., Inc. -1.48%78.650.7%$623.31m
ABBVAbbVie, Inc. -2.26%84.321.9%$591.87m
LLYEli Lilly & Co. -2.37%142.661.1%$506.47m
AZNAstraZeneca Plc -1.11%52.441.2%$199.31m
NVSNovartis AG -0.49%85.770.2%$145.37m
GSKGlaxoSmithKline Plc -1.12%36.160.2%$133.98m
NVONovo Nordisk A/S -0.34%70.780.1%$69.97m
RGENRepligen Corp. -1.18%168.757.1%$62.44m
PRAXPraxis Precision Medicines, Inc. -1.98%27.250.0%$62.40m
RPRXRoyalty Pharma Plc -3.68%40.270.2%$57.90m
SNYSanofi -0.26%50.140.2%$50.33m
AMAGAMAG Pharmaceuticals, Inc. 0.07%13.6422.1%$45.46m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.